Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its ...
Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its ...
Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...
Huahei Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), ...
Understanding what hepatitis C is, how it spreads and how it is treated can replace fear with clarity.
Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its ...
Chinese biotech Huahui Health has won conditional approval for Libevitug (libevitug) to treat adults with chronic hepatitis D ...
China's drug regulator has granted conditional approval to Huahui Health's Libevitug injection for the treatment of the ...
19hon MSNOpinion
HHS has new vaccine rules. They're doomed to fail. | Opinion
Trying to import Denmark's vaccine schedule into the United States is like bolting a jet engine onto a toy plane.
The U.S. is cutting the Hepatitis B vaccine from its recommended list. But here's a place where the medical establishment — ...
Instead of focusing on your sore arm after your next vaccine, you might want to think good thoughts. A new study that trained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results